| Teva Pharmaceutical Industries Limited (TEVA) | |||
|---|---|---|---|
| 7.05 -0.21 (-2.89%) | 08-23 16:02 | ||
| Open: | 7.22 | Pre. Close: | 7.26 |
| High: | 7.38 | Low: | 7.01 |
| Volume: | 15,311,489 | Market Cap: | 7758M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 7.388 - 7.428 | 7.428 - 7.461 |
| Low: | 7.062 - 7.113 | 7.113 - 7.154 |
| Close: | 6.976 - 7.051 | 7.051 - 7.113 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 8.60  One year: 9.53 |
| Support: | Support1: 6.07 Support2: 5.05 |
| Resistance: | Resistance1: 7.36 Resistance2: 8.16 |
| Pivot: | 6.99 |
| Moving Averages: | MA(5): 7.10 MA(20): 7.21 MA(100): 10.36 MA(250): 15.93 |
| MACD: | MACD(12,26): -0.35 Signal(12,26,9): -0.44 |
| %K %D: | %K(14,3): 60.42 %D(3): 55.10 |
| RSI: | RSI(14): 43.84 |
| 52-Week: | High: 25.13 Low: 6.07 Change(%): -69.4 |
| Average Vol(K): | 3-Month: 1999619 10-Days: 2143650 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.TEVA has closed below upper band by 46.7%. Bollinger Bands are 33.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
Fri, 23 Aug 2019 23:08:46 Z Will Lawsuits Sink Johnson & Johnson Stock? Fri, 23 Aug 2019 16:13:55 Z J&J's (JNJ) Opioid Lawsuit Verdict in Oklahoma Due Next Week Thu, 22 Aug 2019 17:13:02 Z BeiGene's NDA for Zanubrutinib Gets Priority Review From FDA Thu, 22 Aug 2019 14:19:58 Z Mallinckrodt (MNK) Stock Down 70.8% YTD on Numerous Lawsuits Wed, 21 Aug 2019 20:09:42 Z Endo Up on Settlement of a Few Cases Related to Opioid Drugs |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency |  |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Specialty Generic | |
| Shares Out. (M) | 1090.00 |
| Shares Float (M) | 1000.00 |
| % Held by Insiders | 3.95 |
| % Held by Institutions | 63.54 |
| Shares Short (K) | 51570 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | -3.790 |
| EPS Est. Current Year | 4.230 |
| EPS Est. Next Year | 3.690 |
| EPS Est. Next Quarter | 1.090 |
| Forward EPS | 2.790 |
| Book Value (p.s.) | 12.930 |
| PEG Ratio | -0.84 |
| Profit Margin | -21.94 |
| Operating Margin | 14.77 |
| Return on Assets (ttm) | 2.6 |
| Return on Equity (ttm) | -24.3 |
| Qtrly Rev. Growth | -7.7 |
| Gross Profit (p.s.) | 7.615 |
| Sales Per Share | |
| EBITDA (p.s.) | 4.009 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 673.00 |
| Levered Free Cash Flow (M) | 2190.00 |
| Stock Valuation | |
|---|---|
| P/E | -1.86 |
| P/E Growth Ratio | -0.03 |
| P/BV | 0.55 |
| P/S | 458502400.00 |
| P/CF | 11.42 |
| Dividend Yield | |
| Dividends & Splits | |
|---|---|
| Dividend | |
| Dividend Pay Date | 2017-12-12 |
| Ex-Dividend Date | 2017-11-27 |
| Forward Dividend | |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
